Maharashtra, India

Sameer Shankar Walunj

This inventor holds 1 USPTO granted patent. Top assignee: Lupin, Inc.. Active years: 2009.


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sameer Shankar Walunj: Innovator in Medical Composition

Introduction

Sameer Shankar Walunj is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of medical compositions, particularly in the treatment of psoriasis and other disorders. His innovative work has led to the development of a unique composition that has potential therapeutic applications.

Latest Patents

Sameer holds a patent for a "Purified Arabinogalactan-Protein (AGP) composition useful in the treatment of psoriasis and other disorders." This composition is isolated through a selective method from the leaves and/or stems of plants. The patent describes the AGP composition, which exhibits various effects, including immunosuppression, lymphoproliferation inhibition, cytokine modulation, keratinocyte proliferation inhibition, keratolytic activity, and inhibitory activity in the Mouse Ear Swelling test (MEST). He has 1 patent to his name.

Career Highlights

Sameer is currently associated with Lupin, Inc., a prominent pharmaceutical company. His work at Lupin has allowed him to focus on innovative solutions in the medical field. His dedication to research and development has positioned him as a valuable asset in the industry.

Collaborations

Throughout his career, Sameer has collaborated with talented individuals such as Sudershan Kumar Arora and Vandita Srivastava. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Sameer Shankar Walunj is a distinguished inventor whose work in medical compositions has the potential to impact the treatment of various disorders. His contributions to the field exemplify the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…